Press releases
| Jun 2011 |
BMEYE Launches a Noninvasive, Breakthrough Parameter for Delivery of Oxygen (DO2I) and new Fluid Management Parameters at the European Society of Anesthesia Congress (read full article) |
|
|
| Dec 2010 |
BMEYE and PULSION Sign Licensing Agreement (read full article) |
|
|
| Nov 2010 |
BMEYE Receives FDA Clearance to Launch ccNexfin, The First Totally Noninvasive Cardiovascular Monitor With BP, CO, And Masimo Rainbow SET® (read full article) |
|
|
| Jun 2010 |
BMEYE B.V. Selected as a Red Herring Top 100 Europe Technology Startup (read full article) |
|
|
| Oct 2009 |
BMEYE B.V. completes € 6 million Series B financing round (read full article) |
|
|
| Jan 2009 |
BMEYE Receives CE Mark to Launch First Noninvasive Cardiovascular Monitor with Masimo Rainbow SET® Pulse CO-Oximetry™ Technology in Europe (read full article) |
|
|
| Dec 2007 |
BMEYE announces FDA 510(K) Clearance for Nexfin (read full article) |
|
|
| Jul 2007 |
BMEYE Announces CE Mark Approval (read full article) |
|
|
| Sep 2006 |
LSP leads € 3 million Financing of BMEYE (read full article) |
|
